Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhanqun Yang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 10, 2024
Human serum albumin promotes interactions between HSA-IL-2 fusion protein and CD122 for enhancing immunotherapyKaiyue Zuo, Naiyu Liu, Peng Zhou, et al.
Bioengineering & Translational Medicine|January 23, 2023
Nanoalbumin-prodrug conjugates prepared via a thiolation-and-conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8<sup>+</sup> T-cell infiltrationLong Chen, Nuo Xu, Pan Wang, et al.
ACS Omega|November 17, 2025
A LRELHLNNN-Gal‑3 Modified Adipose Decellularized Scaffold To Construct Colorectal Cancer Model for Anticancer Drug Screening and ImmunotherapyWei Liang, Hui Li, Rigele Ao, et al.
Mechanisms of Ageing and Development|July 17, 2024
Sestrin2 plays a protective role in age-related hearing loss by inhibiting NLRP3-inflammasome activityLiting Zheng, Menghua Li, Yalan Li, et al.
Medcomm|January 9, 2025
Chemical cross-linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual-antigen subunit vaccineLong Chen, Chao Shang, Zihao Wang, et al.
National Science Review|August 22, 2025
Chemical engineering of γδ T cells with cancer cell-targeting antibodies for enhanced tumor immunotherapyLong Chen, Bo Cheng, Zhanqun Yang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 10, 2024
Human serum albumin promotes interactions between HSA-IL-2 fusion protein and CD122 for enhancing immunotherapyKaiyue Zuo, Naiyu Liu, Peng Zhou, et al.
Bioengineering & Translational Medicine|January 23, 2023
Nanoalbumin-prodrug conjugates prepared via a thiolation-and-conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8<sup>+</sup> T-cell infiltrationLong Chen, Nuo Xu, Pan Wang, et al.
ACS Omega|November 17, 2025
A LRELHLNNN-Gal‑3 Modified Adipose Decellularized Scaffold To Construct Colorectal Cancer Model for Anticancer Drug Screening and ImmunotherapyWei Liang, Hui Li, Rigele Ao, et al.
Mechanisms of Ageing and Development|July 17, 2024
Sestrin2 plays a protective role in age-related hearing loss by inhibiting NLRP3-inflammasome activityLiting Zheng, Menghua Li, Yalan Li, et al.
Medcomm|January 9, 2025
Chemical cross-linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual-antigen subunit vaccineLong Chen, Chao Shang, Zihao Wang, et al.
National Science Review|August 22, 2025
Chemical engineering of γδ T cells with cancer cell-targeting antibodies for enhanced tumor immunotherapyLong Chen, Bo Cheng, Zhanqun Yang, et al.
Pageof 1